oncological patients undergoing therapy (regardless of the form of therapy)
Conditions
Interventions
Group 1: In the study, data is collected based on a one-time survey using a questionnaire (completed independently by the patient). The validated PG SGA sf questionnaire is used to record the risk o
Sponsors
UCCH- Universitätsklinikum Hamburg Eppendorf
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: • Oncological patient at the UCCH (outpatient/inpatient) • Age = 18 years, all genders • Cognitive and mental health • Existence of the declaration of consent
Exclusion criteria
Exclusion criteria: • Advanced dementia • Patients requiring intensive care
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Assessment of the frequency of the occurrence of side effects (listing of common side effects - patient markes the side effects that affect him and also has the option of adding side effects that are not listed using free text) | — |
Secondary
| Measure | Time frame |
|---|---|
| - Assessment of weight and weight history - Assessment of risk of malnutrition (measured using PG SGA Short Form) - Detailed recording of the change in taste and smell (sensation in the mouth, cause of the problem) - Assessment the need and desire for nutritional advice and content | — |
Countries
Germany
Contacts
Public ContactMarianne Sinn
Universitätsklinikum Hamburg Eppendorf
Outcome results
None listed